GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (WBO:JNJ) » Definitions » Cash-to-Debt

Johnson & Johnson (WBO:JNJ) Cash-to-Debt

: 0.78 (As of Dec. 2023)
View and export this data going back to 2017. Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Johnson & Johnson's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.78.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Johnson & Johnson couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Johnson & Johnson's Cash-to-Debt or its related term are showing as below:

WBO:JNJ' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.53   Med: 0.75   Max: 1.93
Current: 0.78

During the past 13 years, Johnson & Johnson's highest Cash to Debt Ratio was 1.93. The lowest was 0.53. And the median was 0.75.

WBO:JNJ's Cash-to-Debt is ranked worse than
53.91% of 1048 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs WBO:JNJ: 0.78

Johnson & Johnson Cash-to-Debt Historical Data

The historical data trend for Johnson & Johnson's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Johnson & Johnson Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 0.71 0.94 0.56 0.78

Johnson & Johnson Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash-to-Debt Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.47 0.63 0.79 0.78

Competitive Comparison

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson Cash-to-Debt Distribution

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Cash-to-Debt falls into.



Johnson & Johnson Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Johnson & Johnson's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Johnson & Johnson's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Johnson & Johnson  (WBO:JNJ) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Johnson & Johnson Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson (WBO:JNJ) Business Description

Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.